TY - CHAP M1 - Book, Section TI - Genetic Testing A1 - McGowan, Michelle L. A1 - Fishler, Kristen A1 - Dryburgh, David Edul A1 - Saito, Kenji A2 - Quang, Tony S. A2 - Taft, Michelle S. A2 - Beriwal, Sushil PY - 2022 T2 - Understanding the Principles and Practice of Legal Oncology AB - Both germline and somatic mutations contribute to tumor pathogenesis. The integration of genetic and genomic sequencing into cancer care has unveiled the presence of unique mutations that characterize tumors based on their molecular origins.1 In some cases, specific molecularly targeted therapies may be incorporated into a personalized treatment plan based on the presence of a particular mutation biomarker.2–5 SN - PB - McGraw Hill Education CY - New York, NY Y2 - 2024/03/28 UR - hemonc.mhmedical.com/content.aspx?aid=1191392548 ER -